全文获取类型
收费全文 | 59867篇 |
免费 | 4504篇 |
国内免费 | 524篇 |
专业分类
耳鼻咽喉 | 689篇 |
儿科学 | 1555篇 |
妇产科学 | 1101篇 |
基础医学 | 8724篇 |
口腔科学 | 904篇 |
临床医学 | 5606篇 |
内科学 | 13311篇 |
皮肤病学 | 1213篇 |
神经病学 | 5374篇 |
特种医学 | 2244篇 |
外国民族医学 | 19篇 |
外科学 | 8471篇 |
综合类 | 1422篇 |
现状与发展 | 1篇 |
一般理论 | 8篇 |
预防医学 | 3974篇 |
眼科学 | 1095篇 |
药学 | 4425篇 |
6篇 | |
中国医学 | 712篇 |
肿瘤学 | 4041篇 |
出版年
2023年 | 330篇 |
2022年 | 815篇 |
2021年 | 1479篇 |
2020年 | 919篇 |
2019年 | 1297篇 |
2018年 | 1577篇 |
2017年 | 1166篇 |
2016年 | 1206篇 |
2015年 | 1510篇 |
2014年 | 1931篇 |
2013年 | 2569篇 |
2012年 | 3793篇 |
2011年 | 3887篇 |
2010年 | 2426篇 |
2009年 | 2075篇 |
2008年 | 3211篇 |
2007年 | 3334篇 |
2006年 | 3153篇 |
2005年 | 3144篇 |
2004年 | 2905篇 |
2003年 | 2840篇 |
2002年 | 2691篇 |
2001年 | 1540篇 |
2000年 | 1464篇 |
1999年 | 1390篇 |
1998年 | 715篇 |
1997年 | 627篇 |
1996年 | 529篇 |
1995年 | 494篇 |
1994年 | 429篇 |
1993年 | 409篇 |
1992年 | 779篇 |
1991年 | 726篇 |
1990年 | 667篇 |
1989年 | 645篇 |
1988年 | 623篇 |
1987年 | 565篇 |
1986年 | 558篇 |
1985年 | 505篇 |
1984年 | 398篇 |
1983年 | 327篇 |
1982年 | 245篇 |
1981年 | 208篇 |
1980年 | 190篇 |
1979年 | 313篇 |
1978年 | 173篇 |
1977年 | 203篇 |
1974年 | 182篇 |
1973年 | 176篇 |
1972年 | 174篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
Aaron M Kipp Jennifer A Lehman Richard A Bowen Patricia E Fox Michael R Stephens Kaci Klenk Nicholas Komar Michel L Bunning 《The American journal of tropical medicine and hygiene》2006,75(4):688-690
To better understand the potential environmental health risk presented by West Nile virus (WNV)-contaminated feces, we quantified the amount of WNV present in the feces of experimentally infected American crows (Corvus brachyrhynchos) and fish crows (Corvus ossifragus). Peak fecal titers ranged from 10(3.5) to 10(8.8) plaque-forming units (PFU)/g for 10 American crows and from 10(2.3) to 10(6.4) PFU/g for 10 fish crows. The presence of infectious WNV in bird feces indicates a potential for direct transmission of WNV. Thus, handlers of sick or dead birds should take appropriate precautions to avoid exposure to fecal material. 相似文献
43.
44.
45.
目的评估十二指肠-空肠导管(Endoluminal Duodeno-Jejunal Tube,EDJT)在活体猪实验动物模型中减缓体重增加的可行性,及其在中短期生存中的安全性。方法本项研究共用8只45kg重的Yorkshire猪,其中3只置入180emEDJT,1只置入360cm EDJT,另4只猪作为对照组。切开十二指肠,将EDJT导管缝合固定在十二指肠近Vater壶腹起始处。结果评估全部猪的不适反应和体重,每日一次,共7周,未发现严重并发症发生。术后7周3组动物的平均体重变化百分率:对照组、180cm组和360cm组分别是22.5%,6%和-2.8%。EDJT组(180cm组、360cm组)体重增加明显减慢,与对照组相比,有统计学意义(P=0.05)。结论EDJT可以安全使用,无肠梗阻、肠套叠或胰腺炎等并发症发生。EDJT可明显减缓体重增加。 相似文献
46.
47.
Prof. J. Michel 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》1878,24(1):131-147
Ohne Zusammenfassung 相似文献
48.
Y. Le Meur M. Büchler A. Thierry S. Caillard F. Villemain S. Lavaud I. Etienne P.-F. Westeel B. H. de Ligny L. Rostaing E. Thervet J. C. Szelag J.-P. Rérolle A. Rousseau G. Touchard P. Marquet 《American journal of transplantation》2007,7(11):2496-2503
Efficacy and safety of mycophenolate mofetil (MMF) may be optimized with individualized doses based on therapeutic monitoring of its active metabolite, mycophenolic acid (MPA). In this 12-month study, 137 renal allograft recipients from 11 French centers receiving basiliximab, cyclosporine A, MMF and corticosteroids were randomized to receive either concentration-controlled doses or fixed-dose MMF. A novel Bayesian estimator of MPA AUC based on three-point sampling was used to individualize doses on posttransplant days 7 and 14 and months 1, 3 and 6. The primary endpoint was treatment failure (death, graft loss, acute rejection and MMF discontinuation). Data from 65 patients/group were analyzed. At month 12, the concentration-controlled group had fewer treatment failures (p = 0.03) and acute rejection episodes (p = 0.01) with no differences in adverse event frequency. The MMF dose was higher in the concentration-controlled group at day 14 (p < 0.0001), month 1 (p < 0.0001) and month 3 (p < 0.01), as were median AUCs on day 14 (33.7 vs. 27.1 mg*h/L; p = 0.0001) and at month 1 (45.0 vs. 30.9 mg*h/L; p < 0.0001). Therapeutic MPA monitoring using a limited sampling strategy can reduce the risk of treatment failure and acute rejection in renal allograft recipients 12 months posttransplant with no increase in adverse events. 相似文献
49.
Carel Bron Michel Wensing Jo LM Franssen Rob AB Oostendorp 《BMC musculoskeletal disorders》2007,8(1):107
Background
Shoulder disorders are a common health problem in western societies. Several treatment protocols have been developed for the clinical management of persons with shoulder pain. However available evidence does not support any protocol as being superior over others. Systematic reviews provide some evidence that certain physical therapy interventions (i.e. supervised exercises and mobilisation) are effective in particular shoulder disorders (i.e. rotator cuff disorders, mixed shoulder disorders and adhesive capsulitis), but there is an ongoing need for high quality trials of physical therapy interventions. Usually, physical therapy consists of active exercises intended to strengthen the shoulder muscles as stabilizers of the glenohumeral joint or perform mobilisations to improve restricted mobility of the glenohumeral or adjacent joints (shoulder girdle). It is generally accepted that a-traumatic shoulder problems are the result of impingement of the subacromial structures, such as the bursa or rotator cuff tendons. Myofascial trigger points (MTrPs) in shoulder muscles may also lead to a complex of symptoms that are often seen in patients diagnosed with subacromial impingement or rotator cuff tendinopathy. Little is known about the treatment of MTrPs in patients with shoulder disorders. 相似文献50.
Surgery alone has long been the standard treatment for patients with operable non-small-cell lung cancer (NSCLC). However, despite complete resection, 5-year survival rates have been disappointing, with about 50% of patients eventually suffering relapse and death from disease. Randomized trials conducted in the 1980s hinted at a survival benefit for postoperative cisplatin-based regimens, but they were underpowered. A meta-analysis published in 1995 found a nonsignificant 13% reduction in the risk of death associated with cisplatin-based chemotherapy, with an increase of survival of 5% at 5 years. This led to renewed interest in adjuvant chemotherapy in resected NSCLC. Thousands of patients have been included in a new generation of randomized trials in the last 10 years. Most of these recent studies have now been reported and several have demonstrated a clear survival advantage for patients treated with platin-based adjuvant therapy. These results also suggest a greater benefit with modern two-drug regimens. In view of the most recent data, postoperative platin-based chemotherapy can now be considered the standard of care for completely resected NSCLC patients with good performance status. 相似文献